two new IV platelet inhibitors

July 1998

The FDA just approved two new IV plateletinhibitors...Aggrastat (tirofiban) and Integrilin (eptifibatide).

They're being called "super aspirins"...because they're morepotent than aspirin. In fact, these new drugs are similar toproteins in snake venom that cause bleeding.

Aggrastat or Integrilin are for treating unstableangina...certain types of heart attacks...and angioplasty.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

drug interactions are in the news again
Women's Health Prometrium, the first commercially available form of ORAL micronized progesterone
Pediatrics shorter course of antibiotics for uncomplicated ear infections
Hepatitis C Rebetron, a new combination treatment for chronic hepatitis C
Vitamin E seems to reduce the risk of prostate cancer
7-keto DHEA
Diabetes replacing SureStep meters made before August '97
Diabetes what diabetes products and educational services will be covered
Cardiology two new IV platelet inhibitors
the best way to prevent and treat mosquito bites
Neurology & Pain aspartame (Nutrasweet, Equal) for arthritic pain
Transdermal Patches whether it's okay to cut patches in half
Gastroenterology Pepto-Bismol (bismuth subsalicylate) reduces gas odor
Practice paying pharmacies $10 for getting a patient to bring in their recalled EpiPens

two new IV platelet inhibitors

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents